Prestwich Pharmacy Limited - Accounts to registrar (filleted) - small 18.2

Prestwich Pharmacy Limited - Accounts to registrar (filleted) - small 18.2


IRIS Accounts Production v18.2.1.62 04934939 Board of Directors 1.12.16 30.11.17 30.11.17 true false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure049349392016-11-30049349392017-11-30049349392016-12-012017-11-30049349392015-11-30049349392015-12-012016-11-30049349392016-11-3004934939ns15:EnglandWales2016-12-012017-11-3004934939ns14:PoundSterling2016-12-012017-11-3004934939ns10:Director12016-12-012017-11-3004934939ns10:PrivateLimitedCompanyLtd2016-12-012017-11-3004934939ns10:SmallEntities2016-12-012017-11-3004934939ns10:AuditExempt-NoAccountantsReport2016-12-012017-11-3004934939ns10:SmallCompaniesRegimeForDirectorsReport2016-12-012017-11-3004934939ns10:SmallCompaniesRegimeForAccounts2016-12-012017-11-3004934939ns10:FullAccounts2016-12-012017-11-3004934939ns10:Director22016-12-012017-11-3004934939ns10:Director32016-12-012017-11-3004934939ns10:Director42016-12-012017-11-3004934939ns10:CompanySecretary12016-12-012017-11-3004934939ns10:RegisteredOffice2016-12-012017-11-3004934939ns5:CurrentFinancialInstruments2017-11-3004934939ns5:CurrentFinancialInstruments2016-11-3004934939ns5:ShareCapital2017-11-3004934939ns5:ShareCapital2016-11-3004934939ns5:SharePremium2017-11-3004934939ns5:SharePremium2016-11-3004934939ns5:RetainedEarningsAccumulatedLosses2017-11-3004934939ns5:RetainedEarningsAccumulatedLosses2016-11-3004934939ns5:LeaseholdImprovements2016-12-012017-11-3004934939ns5:PlantMachinery2016-12-012017-11-3004934939ns5:FurnitureFittings2016-12-012017-11-3004934939ns5:LeaseholdImprovements2016-11-3004934939ns5:PlantMachinery2016-11-3004934939ns5:FurnitureFittings2016-11-3004934939ns5:LeaseholdImprovements2017-11-3004934939ns5:PlantMachinery2017-11-3004934939ns5:FurnitureFittings2017-11-3004934939ns5:LeaseholdImprovements2016-11-3004934939ns5:PlantMachinery2016-11-3004934939ns5:FurnitureFittings2016-11-3004934939ns5:CostValuation2016-11-3004934939ns5:CurrentFinancialInstrumentsns5:WithinOneYear2017-11-3004934939ns5:CurrentFinancialInstrumentsns5:WithinOneYear2016-11-3004934939ns5:CurrentFinancialInstruments2016-12-012017-11-30


REGISTERED NUMBER: 04934939 (England and Wales)















Unaudited Financial Statements for the Year Ended 30 November 2017

for

PRESTWICH PHARMACY LIMITED

PRESTWICH PHARMACY LIMITED (REGISTERED NUMBER: 04934939)

Contents of the Financial Statements
for the Year Ended 30 November 2017










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


PRESTWICH PHARMACY LIMITED

Company Information
for the Year Ended 30 November 2017







DIRECTORS: Mr F G McCaul
Mrs H Hughes
Mr H Hughes
Mr M Williams



SECRETARY: Mrs H Hughes



REGISTERED OFFICE: Century Buildings
14 St. Mary's Parsonage
Manchester
M3 2DF



REGISTERED NUMBER: 04934939 (England and Wales)



ACCOUNTANTS: BTMR Limited
Century Buildings
14 St Mary's Parsonage
Manchester
M3 2DF



BANKERS: Lloyds TSB Bank Plc
Burnley Branch
Burnley
Lancashire

PRESTWICH PHARMACY LIMITED (REGISTERED NUMBER: 04934939)

Balance Sheet
30 November 2017

30.11.17 30.11.16
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 22,250 38,157
Investments 5 162,981 162,981
185,231 201,138

CURRENT ASSETS
Stocks 171,337 160,568
Debtors 6 174,732 319,349
Cash at bank and in hand 10,267 10,534
356,336 490,451
CREDITORS
Amounts falling due within one year 7 462,391 542,375
NET CURRENT LIABILITIES (106,055 ) (51,924 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

79,176

149,214

CAPITAL AND RESERVES
Called up share capital 10,004 10,004
Share premium 92,668 92,668
Retained earnings (23,496 ) 46,542
SHAREHOLDERS' FUNDS 79,176 149,214

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 November 2017.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 November 2017 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies
Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end
of each financial year and of its profit or loss for each financial year in accordance with the requirements of
Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to
financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small companies.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors on 28 August 2018 and were signed on its behalf by:





Mr F G McCaul - Director


PRESTWICH PHARMACY LIMITED (REGISTERED NUMBER: 04934939)

Notes to the Financial Statements
for the Year Ended 30 November 2017


1. STATUTORY INFORMATION

Prestwich Pharmacy Limited is a private company, limited by shares , registered in England and Wales. The
company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with the provisions of Section 1A "Small Entities" of Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is accounted for as revenue when, and to the extent that, the company obtains a right to consideration
in exchange for its performance of its obligations under the sales contract with the customer. The amount
reported as revenue is the fair value of the right to consideration - usually the price specified in the contractual
arrangement net of discounts and net of VAT, and after any allowance for credit risk and other uncertainties.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off the cost less estimated residual value of each asset over its estimated useful life.
Improvements to property - 10% on cost
Plant and machinery - 33% on cost and 10% on cost
Fixtures and fittings - 50% on cost and 20% on cost

Tangible fixed assets are initially recorded at cost.

Investments in subsidiaries
Investments in subsidiary undertakings are recognised at cost.

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and
slow moving items.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the
lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension
scheme are charged to profit or loss in the period to which they relate.

Financial instruments
Financial instruments are classified and accounted for, according to the substance of the contractual
arrangement, as either financial assets, financial liabilities or equity instruments. An equity instrument is any
contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Government grants
Deferred government grants in respect of capital expenditure are treated as deferred income and are credited to
the profit and loss account over the estimated useful life of the assets to which they relate.

Government grants in respect of overhead expenditure are matched against the overhead incurred.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 24 .

PRESTWICH PHARMACY LIMITED (REGISTERED NUMBER: 04934939)

Notes to the Financial Statements - continued
for the Year Ended 30 November 2017


4. TANGIBLE FIXED ASSETS
Improvements Fixtures
to Plant and and
property machinery fittings Totals
£    £    £    £   
COST
At 1 December 2016 554,610 245,259 262,975 1,062,844
Additions - 1,534 - 1,534
At 30 November 2017 554,610 246,793 262,975 1,064,378
DEPRECIATION
At 1 December 2016 554,461 244,179 226,047 1,024,687
Charge for year 149 84 17,208 17,441
At 30 November 2017 554,610 244,263 243,255 1,042,128
NET BOOK VALUE
At 30 November 2017 - 2,530 19,720 22,250
At 30 November 2016 149 1,080 36,928 38,157

5. FIXED ASSET INVESTMENTS
Shares in
subsidiary
undertaki
ngs
£   
COST
At 1 December 2016
and 30 November 2017 162,981
NET BOOK VALUE
At 30 November 2017 162,981
At 30 November 2016 162,981

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.11.17 30.11.16
£    £   
Trade debtors 127,369 150,508
Amounts owed by associates - 117,164
Other debtors 47,363 51,677
174,732 319,349

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.11.17 30.11.16
£    £   
Bank loans and overdrafts 30,232 38,627
Trade creditors 264,244 276,485
Amounts owed to associates - 71,299
Taxation and social security 59,013 6,625
Other creditors 108,902 149,339
462,391 542,375

PRESTWICH PHARMACY LIMITED (REGISTERED NUMBER: 04934939)

Notes to the Financial Statements - continued
for the Year Ended 30 November 2017


7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR - continued

Overdrafts are secured by a fixed and floating charge over all current and future assets of the company.

There is an unlimited debenture by way of security for the bank loan. Interest is charged on the loan at 0.85%
above the base rate.

This security applies to creditors due for repayment both within and after more than one year from the balance
sheet date.

8. CONTROLLING PARTY

The controlling party is not known.

The company was under the control of Mr & Mrs H Hughes and Mr F McCaul throughout the period. Mr & Mrs
Hughes and Mr McCaul are directors and shareholders of the company, together with Mr M Williams.